In the March issue

This month's issue includes articles on improving time to PCI, managing an emerging resistant infection, and dealing with drug interactions.


So much of health care is about being in the right place at the right time. For patients requiring percutaneous coronary intervention (PCI), this is particularly true. But since many people do have ST-elevation myocardial infarctions far from PCI capability, our cover story looks at what hospitals, physicians, and emergency medical services are doing to optimize these systems of care. They're studying their own practices and overcoming barriers to collaboration to make sure that cardiac patients receive the care they need, no matter where they are. This month's Success Story also focuses on PCI, describing one hospital's successful effort to reduce readmissions after the procedure.

While some things are getting better, others are getting worse, including the prevalence of Candida auris, a fungus associated with high mortality and resistance to multiple antifungal drugs. Our article offers five facts physicians should know about this infection that has emerged in a few U.S. hospitals. And more drugs might be the solution to this problem, but they're also the cause of problems for many patients, as another article in this issue describes. Learn about new advances in preventing drug-drug interactions, including the use of big data and lab science to identify the dangers of certain combinations.

In other clinical coverage, we have an Expert Analysis on identifying and treating deep venous thrombosis in patients with cancer and an edition of Brief Case that's focused on gastrointestinal problems. This month's Q&A looks at medical education, specifically getting future physicians interested in providing high-value care from the very start.

Have you implemented innovations for improving the value of care at your own hospital? Email us and tell us how.

Sincerely,
Stacey Butterfield
Editor-in-Chief